PropertyValue
?:abstract
  • There is great concern about the impact of COVID-19 among the nearly 40 million people living with HIV (PLWH) worldwide. In this review, we surveyed current literature and found no evidence of higher prevalence of COVID-19 among PLWH but equivocal data on increased mortality and worse clinical outcomes. Having HIV does not confer protection against severe manifestations of COVID-19. Several studies looking at antiretroviral drugs against HIV to treat SARS-CoV-2 have shown no mortality benefit. Thus, there is no indication to change ART regimens among virologically suppressed PLWH to prevent COVID-19. HIV care delivery has been adversely impacted in several countries during this pandemic but has created an opportunity for accelerating effective strategies like multi-month ART. Decentralizing HIV care in low-resource settings and incorporating telemedicine in high-resource settings will be critical in mitigating shocks to healthcare systems in the future.
?:creator
?:doi
  • 10.1016/j.jve.2020.100019
?:doi
?:journal
  • J_Virus_Erad
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/d976b7b869a1d85809cb182415c953400acc81cd.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7560116.xml.json
?:pmcid
?:pmid
?:pmid
  • 33083001.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Impact of COVID-19 on people with HIV: A Review
?:type
?:year
  • 2020-10-15

Metadata

Anon_0  
expand all